Aemetis (AMTX) Cost of Revenue (2011 - 2026)

Aemetis' Cost of Revenue history runs 15 years deep, the most recent figure standing at $51.9 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 8.12% year-over-year to $51.9 million in Q1 2026; TTM through Mar 2026 was $212.6 million, a 12.47% decrease from a year earlier, with the FY2025 full-year figure at $208.7 million, down 22.17% from the prior year.
• Cost of Revenue rose to $51.9 million in Q1 2026 per AMTX's latest filing, from $45.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $77.6 million in Q3 2024 and bottomed at $3.4 million in Q1 2023.
• The 5-year median for Cost of Revenue is $59.2 million (2025), against an average of $57.4 million.
• Across the five-year window, Cost of Revenue plunged 93.75% in 2023 and soared 2025.54% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $67.9 million in 2022, then grew by 3.0% to $69.9 million in 2023, then retreated by 29.84% to $49.0 million in 2024, then declined by 6.34% to $45.9 million in 2025, then increased by 12.9% to $51.9 million in 2026.
• Per Business Quant, the three latest AMTX Cost of Revenue figures stand at $51.9 million (Q1 2026), $45.9 million (Q4 2025), and $59.2 million (Q3 2025).